Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $81.8600 (0.05%) ($81.5800 - $83.7200) on Thu. Apr. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.43% (three month average) | RSI | 68 | Latest Price | $81.8600(0.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.8% a day on average for past five trading days. | Weekly Trend | ABBV advances 4.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(52%) SPLV(38%) VYM(37%) DIA(35%) IVE(34%) | Factors Impacting ABBV price | ABBV will decline at least -1.715% in a week (0% probabilities). VIXM(-26%) UUP(-9%) VXX(-8%) TLT(-5%) IGOV(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.715% (StdDev 3.43%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
5 Day Moving Average | $81.17(0.85%) | 10 Day Moving Average | $78.59(4.16%) | 20 Day Moving Average | $75.05(9.07%) | To recent high | -16.3% | To recent low | 26.9% | Market Cap | $144.424b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |